110 related articles for article (PubMed ID: 12714468)
1. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented.
Raffle AE; Alden B; Quinn M; Babb PJ; Brett MT
BMJ; 2003 Apr; 326(7395):901. PubMed ID: 12714468
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
3. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
5. Laboratory performance measures: evidence against low-risk women explaining low detection rates of high-grade abnormalities.
Mitchell HS
Cytopathology; 2005 Apr; 16(2):77-81. PubMed ID: 15787649
[TBL] [Abstract][Full Text] [Related]
6. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
7. The agreement between self-reported cervical smear abnormalities and screening programme records.
Canfell K; Beral V; Green J; Cameron R; Baker K; Brown A
J Med Screen; 2006; 13(2):72-5. PubMed ID: 16792828
[TBL] [Abstract][Full Text] [Related]
8. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
9. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer.
Agarwal SS; Murthy NS; Sharma S; Sharma KC; Das DK
Neoplasma; 1995; 42(2):93-6. PubMed ID: 7617084
[TBL] [Abstract][Full Text] [Related]
11. Incidence of subsequent abnormal cytology in cervical cancer patients completing five-years of post treatment surveillance without evidence of recurrence.
Orr JM; Barnett JC; Leath CA
Gynecol Oncol; 2011 Sep; 122(3):501-4. PubMed ID: 21714992
[TBL] [Abstract][Full Text] [Related]
12. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
Mitchell H; Hocking J; Saville M
Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
[TBL] [Abstract][Full Text] [Related]
13. The use of cervical screening history data to interpret cervical cancer incidence trends.
Clare J; Edwards D; Bagnall H; Pearmain P; Lawrence G
J Public Health (Oxf); 2008 Jun; 30(2):171-7. PubMed ID: 18296455
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
15. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
[TBL] [Abstract][Full Text] [Related]
16. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
17. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening in Serbia.
Kesić V; Jovićević-Bekić A; Vujnović M
Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
